Urologix, Inc.

ULGX · OTC
Analyze with AI
3/31/2015
12/31/2014
9/30/2014
6/30/2014
Operating Activities
Net Income-$349-$357-$437-$3,525
Dep. & Amort.$111$116$134$140
Deferred Tax$0$0$0-$63
Stock-Based Comp.$16$22$15$42
Change in WC$60$122-$34$126
Other Non-Cash$142$146$0$0
Operating Cash Flow-$34$32-$170-$91
Investing Activities
PP&E Inv.-$8-$12-$3-$7
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$40$0$0
Investing Cash Flow-$4-$47-$3-$7
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$38-$15-$173-$98
Supplemental Information
Beg. Cash$530$545$718$816
End Cash$492$530$545$718
Free Cash Flow-$42$20-$173-$98